EZOFGA
LIVE
Serial Number
98231209
Owner
VIROPHARMA BIOLOGICS LLCAttorney
Karl M. Zielaznicki, Esq.Filing Date
Oct 19, 2023
EZOFGA Trademark
Serial Number: 98231209
EZOFGA is a trademark filed by
VIROPHARMA BIOLOGICS LLC
on October 19, 2023. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently pending registration.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Karl M. Zielaznicki, Esq. Troutman Pepper Locke LLP
875 THIRD AVENUE
C/O IP SERVICES NYC
NEW YORK, NY 10022
United States
Trademark Details
Filing Date
October 19, 2023
Registration Date
Not Registered
Published for Opposition
July 9, 2024
Goods & Services
pharmaceutical products, namely, budesonide oral suspension (BOS) for eosinophilic esophagitis (EoE)
Filing History
ASSIGNED TO EXAMINER
Jan 20, 2026 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 15, 2026 EXRA
SOU EXTENSION 3 GRANTED
Jan 14, 2026 EX3G
SOU EXTENSION 3 FILED
Jan 14, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 14, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 19, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jun 18, 2025 EX2G
SOU EXTENSION 2 FILED
Jun 18, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 18, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 6, 2024 EXRA
SOU EXTENSION 1 GRANTED
Nov 6, 2024 EX1G
SOU EXTENSION 1 FILED
Nov 6, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 6, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 5, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2023 NWOS
NEW APPLICATION ENTERED
Oct 23, 2023 NWAP
